Znn3bq.jpeg
²é¿´: 579  |  »Ø¸´: 0

alan_lyu

гæ (³õÈëÎÄ̳)

[½»Á÷] ¼±Æ¸IVD¿¹Ìå¸ß¼¶¿ÆÑ§¼Ò£¬baseÄϾ©£¬Ó¦½ì²©Ê¿Çë¿´¹ýÀ´£¡

¾ßÌ幤×÷µØµã:
ÄϾ©ÊÐ
н½ð:
Äêн25-50
ѧÀúºÍÑо¿·½Ïò:
²©Ê¿£¬ÉúÎï·½Ïòרҵ
ÕÐÆ¸¸Úλ:
IVD¿¹Ìå¸ß¼¶¿ÆÑ§¼Ò
¹«Ë¾Ãû³Æ:
¹úÄÚÖªÃûÕï¶ÏÊÔ¼ÁÑз¢Ò©Æó
ÁªÏµ·½Ê½:
Mail£ºalan@foreveroffer.com, Wechat£ºlyuten

Position: Sr. Scientist for Antibody engineering
Location: Nanjing, China
Report to: R&D Director

Key Responsibilities:
1.Lead a dynamic group of scientists to work on antibody application for major pharmaceuticals, biotech and diagnostics customers.
2.Improve core competency in the field of antibody engineering platform including lead selection, humanization, optimization, and format development.
3.Integrate platforms of antibody lead generation, optimization and development for designed application.
4.Participate in strategy development on antibody related business and innovation for antibody discovery, therapeutics monitor, companion diagnostics and therapeutic cell isolation etc.
5.Communicate with the commercial teams to provide new product and new applications; investigate key technologies and platforms to boost the product performance.

Qualifications:
1.Ph.D. or Master degree with five years¡¯ experience in immunology, drug discovery, pharmaceutical science or a related field with expertise on single B cell technology, phage display, yeast display, antibody humanization, and affinity maturation.
2.A thorough understanding and hand-on experience in industry setting of antibody lead generation, optimization and characterization of antibody.
3.Playing a key role in scientific leadership, including study design, literature reference research, project direction, and scientific discussion.
4.Multitasking, self-motivating, innovative, and result and detail-oriented.
5.Proactively participating in collaborative projects.
6.Bilingual in English and Chinese, with strong communication skills.

[ À´×Ô°æ¿éȺ ½­ËÕ ]

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ alan_lyu µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 337Çóµ÷¼Á +3 ÑÐs. 2026-04-10 3/150 2026-04-10 16:20 by ľ×Ó¾ý1218
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +19 ŬÁ¦·Ü¶·112 2026-04-08 19/950 2026-04-10 15:50 by Kilig0317
[¿¼ÑÐ] 326Çóµ÷¼Á +3 Shansyn 2026-04-10 3/150 2026-04-10 15:34 by hemengdong
[¿¼ÑÐ] 314Çóµ÷¼Á +23 wakeluofu 2026-04-09 24/1200 2026-04-10 15:31 by MOF_Catal
[¿¼ÑÐ] 285Çóµ÷¼Á +9 AZMK 2026-04-07 11/550 2026-04-10 15:24 by AZMK
[¿¼ÑÐ] ±¾¿Æ211 ¹¤¿Æ085400 280·ÖÇóµ÷¼Á ¿É¿çרҵ +9 LZH£¨µÈ´ýµ÷¼ÁÖÐ 2026-04-10 9/450 2026-04-10 15:12 by hemengdong
[¿¼ÑÐ] 362Çóµ÷¼Á +9 ÎÒÒª¿¼´ó 2026-04-06 13/650 2026-04-10 11:28 by may_ÐÂÓî
[¿¼ÑÐ] ²ÄÁϸ´ÊÔÇóµ÷¼Á +20 xhhdjdjsjks 2026-04-09 20/1000 2026-04-10 10:25 by ËïСС12457
[¿¼ÑÐ] 0703µ÷¼Á +18 ʰ¾ÁÒ¼ 2026-04-04 20/1000 2026-04-09 20:53 by zhouxiaoyu
[¿¼ÑÐ] 085600²ÄÁÏÓ뻯¹¤£¬Çóµ÷¼Á +11 won_qii 2026-04-07 11/550 2026-04-09 17:03 by luoyongfeng
[¿¼ÑÐ] 085400µç×ÓÐÅÏ¢Àࣨ´¨´ó¿ØÖƹ¤³Ì£©Çóµ÷¼Á¿É¿çרҵ ÇóÀÏʦÁªÏµ +3 626776879 2026-04-08 3/150 2026-04-09 16:05 by Öí»á·É
[¿¼ÑÐ] ²ÄÁÏר˶322 +14 ¹þ¹þ¹þºðºðºð¹þ 2026-04-05 14/700 2026-04-09 13:25 by 5268321
[¿¼ÑÐ] 280Çóµ÷¼Á +5 ÙâÙâÒ¹Ò¹ 2026-04-09 8/400 2026-04-09 11:15 by ÙâÙâÒ¹Ò¹
[¿¼ÑÐ] Çóµ÷¼Á£¬ÏÖÔÚ»¹ÄÜÌîµÄ +3 Éϰ¶Ð¡Ó¨¼ÓÓÍ 2026-04-08 3/150 2026-04-08 14:30 by zhq0425
[¿¼ÑÐ] 0854Çóµ÷¼Á +9 ºàÊÏ·¬ÇÑɳ˾ 2026-04-06 10/500 2026-04-07 14:37 by shdgaomin
[¿¼ÑÐ] Çóµ÷¼Á +5 С›g 2026-04-03 5/250 2026-04-06 22:45 by 875465
[¿¼ÑÐ] ¹¤¿Æ370Çóµ÷¼Á +3 äçÐļ弦µ° 2026-04-05 3/150 2026-04-06 10:55 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] 0857´óÀà»·¾³¹¤³ÌBÇøÇóµ÷¼Á +3 ¹¨ÓíÃú 2026-04-05 3/150 2026-04-06 10:22 by À¶ÔÆË¼Óê
[¿¼ÑÐ] µ÷¼Á +3 Àî¹ã»ð 2026-04-05 3/150 2026-04-05 18:57 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 085400µç×ÓÐÅÏ¢319Çóµ÷¼Á£¨½ÓÊÜ¿çרҵµ÷¼Á£© +5 ÐÇÐDz»Õ£ÑÛà¶ 2026-04-03 6/300 2026-04-04 21:50 by hemengdong
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û